• PIH19 CONTRASTE DE MODELOS DE PROBABILIDAD DICOTOMICOS PARA LA ESTIMACION DE PARTOS Y CESAREAS EN UNA ENTIDAD PROMOTORA DE SALUD COLOMBIANA

    Oct 1, 2019, 00:00

  • PRO12 LITERATURE REVIEW OF CHALLENGES AND OPPORTUNITIES IN HEALTH ECONOMIC EVALUATION METHODOLOGY IN RARE DISEASES

    Oct 1, 2019, 00:00

  • PBI7 CASE STUDY: ECONOMICAL ANALYSIS OF WASTE IN BIOLOGICAL PRODUCTS IN AN INSTITUTION IN COLOMBIA

    Oct 1, 2019, 00:00

  • PSY6 HUMANISTIC AND ECONOMIC BURDEN OF DISEASE FOR PSORIASIS IN ARGENTINA, BRAZIL, COLOMBIA AND MEXICO

    Oct 1, 2019, 00:00

  • PNS50 ANALISIS DE IMPACTO DE LA IMPLEMENTACION DE UNA RED INTEGRADA MEDIANTE LA MEDIDA DE CALIDAD DE VIDA RELACIONADA CON LA SALUD EN POBLACION COLOMBIANA

    Oct 1, 2019, 00:00

  • PMD8 COST-EFFECTIVENESS OF THERMOABLATION VERSUS SURGERY FOR TREATMENT OF LIVER METASTASIS

    Oct 1, 2019, 00:00

  • PBI11 ESTUDIOS DE SINTESIS Y TOMA DE DECISIONES: A PROPOSITO DE LA CONTINUACION DEL TRATAMIENTO CON UN BIOSIMILAR EN PACIENTES QUE RECIBEN INFLIXIMAB EN EL SEGURO SOCIAL EN SALUD EN PERU

    Oct 1, 2019, 00:00

  • PSU4 BUDGET IMPACT ANALYSIS OF TRICLOSAN-COATED SUTURES FOR SURGICAL SITE INFECTION PREVENTION IN COLOMBIA

    Oct 1, 2019, 00:00

  • EP1 SCHOOL ENVIRONMENT FACTORS ASSOCIATED WITH ADOLESCENTS BMI IN BRAZIL

    Oct 1, 2019, 00:00

  • CL3 ESTUDIO DE EVALUACIÃN ECONÃMICA DEL APÃSITO TRANSPARENTE IMPREGNADO CON CLORHEXIDINA, PARA LA FIJACIÃN DE CATÃTERES CENTRALES BAJO EL CONTEXTO DE LOS HOSPITALES PÃBLICOS DE REPáBLICA DOMINICANA: CASO HOSPITAL DOCENTE PADRE BILLINI, AÃO ...

    Oct 1, 2019, 00:00

  • PNS24 GASTOS COM MEDICAMENTOS E SEU IMPACTO NA RENDA DAS FAMÍLIAS BRASILEIRAS

    Oct 1, 2019, 00:00

  • PIH6 APPROACH TO THE IMPACT OF COVERAGE IN LONG-TERM CONTRACEPTION IN THE ECONOMIC BURDEN OF UNPLANNED PREGNANCY FROM THE PERSPECTIVE OF ISAPRES IN CHILE

    Oct 1, 2019, 00:00

  • PNS1 ¿EXISTE SUFICIENTE EVIDENCIA PARA USAR SUPERVIVENCIA GLOBAL Y CALIDAD DE VIDA COMO DESENLACES CRÍTICOS EN LA TOMA DE DECISIONES EN SALUD?

    Oct 1, 2019, 00:00

  • PCN45 COMPARATIVE ANALYSIS OF BRA CMED, GER G-BA AND FRA HAS ASSESSMENT SCORES FOR ONCOLOGY THERAPIES

    Oct 1, 2019, 00:00

  • PIN22 LOS COSTOS DE LA NEUMONIA ADQUIRIDA EN LA COMUNIDAD Y LA LACTANCIA MATERNA COMO FACTOR DE PROTECCION EN MENORES DE 5 ANHOS EN HOSPITAL PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • CR3 COSTOS DIRECTOS Y CUMPLIMIENTO DE INDICADORES DE CONTROL METABOLICO EN PACIENTES CON DIABETES MELLITUS TIPO 2 EN UN HOSPITAL PUBLICO DE COLOMBIA

    Oct 1, 2019, 00:00

  • PIH10 NATIONWIDE, REAL-WORLD HEALTH INSURANCE TREATMENT COST OF INFERTILITY IN HUNGARY: A COST OF ILLNESS STUDY

    Oct 1, 2019, 00:00

  • PCV7 BUDGET IMPACT OF GLOBAL LONGITUDINAL STRAIN FOR THE EARLY DETECTION OF CARDIOTOXICITY INCORPORATION IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PMS2 SUCCESSFUL IMPLEMENTATION OF A COMPREHENSIVE CARE PROGRAM IN RHEUMATOID ARTHRITIS WITH SIGNIFICANT COST-SAVINGS FOR THE HEALTH SYSTEM

    Oct 1, 2019, 00:00

  • PNS30 CHANGES IN THE OWNERSHIP STRUCTURE OF HUNGARIAN HEALTH CARE PROVIDERS

    Oct 1, 2019, 00:00

  • PCN12 COST-EFFECTIVENESS OF PEMBROLIZUMAB COMPARED TO CHEMOTHERAPY AS A TREATMENT FOR PATIENTS WITH PREVIOUSLY TREATED ADVANCED MELANOMA IN CHINA

    Oct 1, 2019, 00:00

  • PUK5 POTENTIALLY INAPPROPRIATE PRESCRIPTIONS OF ANTICHOLINERGIC DRUGS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

    Oct 1, 2019, 00:00

  • PNS49 EVOLUTION AND RESULTS OF HEALTHCARE PERFORMANCE INDICATORS IN BRAZILIAN SELF-FUNDED HEALTH PLANS

    Oct 1, 2019, 00:00

  • CM2 REMOTE MONITORING AFTER THE IMPLANTATION OF A CARDIOVERTER-DEFIBRILLATOR: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2019, 00:00

  • EP4 HOW IS SELF-PERCEIVED HEALTH STATUS (EQ-5D) ASSOCIATED WITH SOCIOECONOMIC CONDITIONS IN 22 LATIN AMERICAN COUNTRIES?

    Oct 1, 2019, 00:00

  • PIT7 THE PROFILE OF FIREARMS INJURIES IN BRAZIL BETWEEN 2009 AND 2016

    Oct 1, 2019, 00:00

  • PCN29 TENDENCIAS EN LA MORTALIDAD DEL CANCER DE MAMA EN COLOMBIA EN MUJERES MAYORES DE 60 AÑOS

    Oct 1, 2019, 00:00

  • PDG9 EVALUACIÓN PARA LA SELECCIÓN DE PRECIO MÁXIMO DE VENTA DE MEDICAMENTOS

    Oct 1, 2019, 00:00

  • PRS9 ESTIMATIVA DO CUSTO DA ASMA EM UM PLANO DE SAUDE NO BRASIL - ESTUDO DE MUNDO REAL

    Oct 1, 2019, 00:00

  • PIH15 CURRENT PANORAMA OF THE SURGICAL TREATMENT OF ENDOMETRIOSIS BY THE BRAZILIAN PUBLIC SYSTEM

    Oct 1, 2019, 00:00

  • PNS31 A VIA ADMINISTRATIVA COMO UMA ALTERNATIVA DE ACESSO AO MEDICAMENTO NO SISTEMA ÚNICO DE SAÚDE: SOLUÇÃO OU PROBLEMA?

    Oct 1, 2019, 00:00

  • PDG16 ACESSO A INFORMAÇÕES E SERVIÇOS PRESTADOS PELA SUPERINTENDÊNCIA DE ASSISTÊNCIA FARMACÊUTICA DO ESTADO DE MINAS GERAIS POR MEIO DO APLICATIVO MGAPP

    Oct 1, 2019, 00:00

  • PCV9 IMPACTO CLINICO Y ECONOMICO DE LAS ENFERMEDADES CARDIOVASCULARES (ECV) EN LA POBLACION ADULTA DENTRO DEL SISTEMA DE SALUD DE MEXICO.

    Oct 1, 2019, 00:00

  • PCN17 COSTO-EFECTIVIDAD DE AFATINIB COMO PRIMERA LÍNEA EN EL TRATAMIENTO DEL CÁNCER DE PULMÓN DE CÉLULAS NO PEQUEÑAS AVANZADO CON MUTACIÓN POSITIVA DEL RECEPTOR DEL FACTOR DE CRECIMIENTO EPIDÉRMICO EN COLOMBIA

    Oct 1, 2019, 00:00

  • PNS29 CHANGING OF HEALTH CARE TOURISM AND ITS RECOVERING ROLE FOR ECONOMY

    Oct 1, 2019, 00:00

  • PNS46 ATENCION VIRTUAL EN SALUD: DE LA ESTRATEGIA A LA TACTICA

    Oct 1, 2019, 00:00

  • PND11 ECONOMIC IMPACT OF INITIATING DIMETHYL FUMARATE VERSUS OTHER DISEASE MODYFING THERAPIES IN PUBLICLY INSURED BRAZILIAN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS

    Oct 1, 2019, 00:00

  • PRS7 ¿REALMENTE ES UNA AMENAZA PARA LA SALUD DE LOS COLOMBIANOS?

    Oct 1, 2019, 00:00

  • PSY1 SECUKINUMAB VS ADALIMUMAB E INFLIXIMAB PARA EL TRATAMIENTO DE ESPONDILITIS ANQUILOSANTE: UN ANÁLISIS DE COSTO POR RESPONDEDOR A LA SEMANA 24 DESDE UNA PERSPECTIVA ECUATORIANA

    Oct 1, 2019, 00:00

  • PNS39 HOW VALUE IS DEFINED BY DIFFERENT STAKEHOLDERS IN BRAZIL?

    Oct 1, 2019, 00:00

  • RE1 THE IMPACT OF REAL-WORLD EVIDENCE ON REIMBURSEMENT SUBMISSIONS: ARE WE CLEAR ON CURRENT PRACTICES?

    Oct 1, 2019, 00:00

  • TP3 Estudio de utilizacion de drogas: Descripción del uso de inmunoglobulina intravenosa humana en un Hospital Universitario de Bogotá, Colombia

    Oct 1, 2019, 00:00

  • PMH2 THE ENVIRONMENT DISASTER OF BRAZILIAN MINING OF MARIANA IN THE HEALTH ECONOMIC CONTEXT: PSYCHOLOGICAL TRAGEDY COST

    Oct 1, 2019, 00:00

  • PCN25 COST-EFFECTIVENESS OF NIVOLUMAB IN FIRST-LINE TREATMENT OF ADVANCED MELANOMA REGARDLESS OF BRAF MUTATION STATUS FROM A BRAZILIAN PUBLIC HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PSY11 ADESAO E CUSTOS ASSOCIADOS AO TRATAMENTO PROFILATICO DE PACIENTES HEMOFILICOS NO BRASIL

    Oct 1, 2019, 00:00

  • PNS54 AUDITORIA SOCIAL COMO FERRAMENTA DE ANALISE DA QUALIDADE DO ATENDIMENTO NA SAUDE

    Oct 1, 2019, 00:00

  • PDG8 COST-EFFECTIVENESS ANALYSIS OF MIDOSTAURIN (MIDO) + INTENSIVE CHEMOTHERAPY (SOC) FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA IN ADULTS WITH FLT3 MUTATION IN COLOMBIA

    Oct 1, 2019, 00:00

  • PRO8 PROFILAXIS EN HEMOFILIA A CON INHIBIDORES EN COLOMBIA, ¿ES POSIBLE CONTAR CON TRATAMIENTOS QUE GENEREN AHORROS AL SISTEMA DE SALUD?

    Oct 1, 2019, 00:00

  • PSY4 BURDEN OF DISEASE FOR RHEUMATOID ARTHRITIS IN COLOMBIA AND BRAZIL

    Oct 1, 2019, 00:00

  • PCN41 IMPACT OF DISEASE RELATED GROUP IN BREAST CANCER TREATMENT IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PDB4 COST-EFFECTIVENESS ANALYSIS OF SWITCHING FROM ALOGLIPTIN TO VILDAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES

    Oct 1, 2019, 00:00

  • PDG11 IMPLEMENTATION OF INDICATORS IN THE PROCESS OF ACQUISITION OF MEDICINES IN THE HOSPITAL UNITS OF THE STATE SECRETARIAT OF HEALTH OF SANTA CATARINA: THE USE OF THE ECONOMIC RATIO INDEX

    Oct 1, 2019, 00:00

  • PIN3 COSTS AND CONSEQUENCES OF CEFTAROLINE FOSAMIL FOR THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) IN BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PSU7 COST-EFFECTIVENESS ANALYSIS OF APIXABAN FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER HIP OR KNEE REPLACEMENT SURGERY IN COLOMBIA

    Oct 1, 2019, 00:00

  • PMH1 COST-OF-ILLNESS STUDIES FOR DEPRESSION AND BIPOLAR DISORDER IN LATIN AMERICA: A SYSTEMATIC REVIEW

    Oct 1, 2019, 00:00

  • PNS2 COLOMBIA'S HEALTHCARE REFORM: COST-CONTAINMENT MECHANISMS AND IMPLICATIONS FOR SUSTAINABILITY

    Oct 1, 2019, 00:00

  • PNS23 EPIDEMIOLOGY OF MYELOPROLIFERATIVE DISORDERS: REAL WORLD DATA STUDY IN BRAZIL

    Oct 1, 2019, 00:00

  • PRS4 HEALTH TECHNOLOGY ASSESSMENT OF DUPILUMAB IN SEVERE BRONCHIAL ASTHMA IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PND5 COST-EFFECTIVENESS OF MECHANICAL THROMBECTOMY USING SOLITAIRE STENT RETRIEVER IN COMBINATION WITH INTRAVENOUS TISSUE PLASMINOGEN ACTIVATOR (IV-TPA) VERSUS IV-TPA ALONE FOR THE TREATMENT OF ACUTE ISCHAEMIC STROKE DUE TO LARGE VESSEL OCC ...

    Oct 1, 2019, 00:00

  • CV4 EVALUACION DE LOS MOTIVOS DE LA OMISION DE RETIROS DE MEDICAMENTOS PENDIENTES EN LA OFICINA DE FARMACIA. POSIBLES SOLUCIONES

    Oct 1, 2019, 00:00

  • PMS3 PSYCHOLOGY CONSULTATION FOR PATIENTS WITH RHEUMATOID ARTHRITIS - A LOW-COST INTERVENTION WITH GREAT BENEFITS

    Oct 1, 2019, 00:00

  • PNS35 THE EFFECT OF FINANCIAL INCENTIVE ON RETAINING DENTISTS IN RURAL AREAS IN THAILAND

    Oct 1, 2019, 00:00

  • PDB1 CALIDAD DE VIDA ASOCIADA CON OBESIDAD EN PACIENTES MEXICANOS

    Oct 1, 2019, 00:00

  • PCN62 PRELIMIANARY ANALYSIS OF TIROSINE KINASE INHIBITOR THERAPY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA A FIVE YEARS FOLLOW-UP FROM A REAL WORLD COHORT

    Oct 1, 2019, 00:00

  • EP2 PUBLIC HEALTH AND ECONOMIC IMPACT OF A QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM FOR FEMALES AGED 9 YEARS IN EL SALVADOR

    Oct 1, 2019, 00:00

  • TP4 REAL-WORLD PATIENT CHARACTERISTICS AND OUTCOMES OF RESECTED STAGE III MELANOMA PATIENTS IN ARGENTINA AND BRAZIL

    Oct 1, 2019, 00:00

  • CN4 ANÁLISIS DE COSTO-UTILIDAD E IMPACTO PRESUPUESTARIO DE LA ENZALUTAMIDA PARA EL TRATAMIENTO DEL CÁNCER DE PRÓSTATA RESISTENTE A LA CASTRACIÓN NO METASTÁSICO (CPRCNM) EN ARGENTINA

    Oct 1, 2019, 00:00

  • PSU2 EFECTIVIDAD Y SEGURIDAD DEL USO DE LOS IMPLANTES DE AHMED, MOLTENO Y BAERVELDT EN PACIENTES OPERADOS CON GLAUCOMA CRONICO: UN META-ANALISIS EN RED

    Oct 1, 2019, 00:00

  • PMH8 EXPERIENCES AND HEALTH NEEDS OF ASYLUM SEEKERS AND REFUGEES OF LATIN AMERICAN ORIGIN IN CHILE

    Oct 1, 2019, 00:00

  • PMS19 MANAGEMENT AND COSTS OF THERAPY FOR OSTEOARTHRITIS

    Oct 1, 2019, 00:00

  • PMU1 POTENTIAL PRODUCTIVITY YEARS OF LIFE LOST RELATED TO DEATHS CAUSED BY RESIDENTIAL RADON AND BONE LEAD IN COLOMBIA, 2016

    Oct 1, 2019, 00:00

  • PIN11 COST-EFFECTIVENESS OF INTERFERON-GAMMA RELEASE ASSAY COMPARED TO TUBERCULIN SKIN TEST FOR DETECTION OF LATENT TUBERCULOSIS IN PATIENTS WITH RENAL FAILURE UNDERGOING HEMODIALYSIS

    Oct 1, 2019, 00:00

  • PSY8 CURRENT PRACTICE AND RESOURCE USE ASSOCIATED WITH TREATMENT OF VENOUS THROMBOEMBOLISM DISEASE IN SOCIAL SECURITY SECTOR OF ARGENTINA

    Oct 1, 2019, 00:00

  • PMD12 HOW MUCH CAN COLOMBIAN HOSPITALS EARN FOR EACH THERAPEUTIC PLASMA EXCHANGE (TPE) PROCEDURE? A MULTI-CENTER, COST COMPARISON STUDY BETWEEN CENTRIFUGAL AND MEMBRANE SYSTEMS

    Oct 1, 2019, 00:00

  • PNS44 COORDENAÇÃO DE CUIDADOS DE SAÚDE ATRAVÉS DE UM APLICATIVO MÓVEL COMO FATOR DE MELHOR RESULTADO CLÍNICO E REDUÇÃO DE CUSTOS

    Oct 1, 2019, 00:00

  • PDB3 PHARMACIST LED INTERVENTION ON HEALTH-RELATED QUALITY OF LIFE OF DIABETIC PATIENTS AND ITS RELATIONSHIP WITH PATIENT DEMOGRAPHICS ON EQ-5D DOMAINS AND VAS SCORE

    Oct 1, 2019, 00:00

  • PMS11 EPIDEMIOLOGY, USE OF RESOURCES AND COST OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN ARGENTINA: AN EXTENSIVE REVIEW WITH EXPERT ELICITATION

    Oct 1, 2019, 00:00

  • PCN1 EFECTIVIDAD Y SEGURIDAD DEL ESQUEMA DABRAFENIB-TRAMETINIB EN EL TRATAMIENTO DEL MELANOMA AVANZADO/METASTÁSICO IRRESECABLE CON MUTACIÓN BRAF V600: REVISIÓN SISTEMÁTICA DE LA LITERATURA Y METANÁLISIS EN RED

    Oct 1, 2019, 00:00

  • PCV4 ANNUAL HEALTH INSURANCE TREATMENT COST OF HYPERTENSIVE RENAL DISEASE IN HUNGARY: COST OF ILLNESS STUDY BASED ON REAL WORLD DATA

    Oct 1, 2019, 00:00

  • PMU11 COMPARATIVE ASSESSMENT OF HTA OUTCOMES IN BRAZIL, CANADA AND THE UNITED KINGDOM

    Oct 1, 2019, 00:00

  • PCN18 ANTINEOPLASICOS ORAIS NA PRIMEIRA LINHA DE TRATAMENTO DE LEUCEMIA MIELOIDE CRONICA: UMA ANALISE DE CUSTO

    Oct 1, 2019, 00:00

  • PRS2 COST ANALYSIS FOR THE TREATMENT OF SEVERE UNCONTROLLED BRONCHIAL ASTHMA IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PMU8 DIFERENCIAS EN LA MORTALIDAD SEGUN LUGAR DE OCURRENCIA Y REGIMEN DE SALUD EN EL CARIBE COLOMBIANO, 2016

    Oct 1, 2019, 00:00

  • PNS14 EVIDENCE ON THE POSTPONEMENT OF MATERNITY IN BRAZIL

    Oct 1, 2019, 00:00

  • PMD4 ANALISIS DE IMPACTO PRESUPUESTARIO SOBRE LA INCORPORACION DEL COCIENTE SFLT-1/PLGF PARA PREDECIR EL RIESGO DE PREECLAMPSIA EN EL SISTEMA DE SALUD PUBLICO DE MENDOZA, ARGENTINA

    Oct 1, 2019, 00:00

  • CN2 EVALUACIÓN DE COSTO-EFECTIVIDAD DE LA ENZALUTAMIDA (ENZA) FRENTE A LA ABIRATERONA (ABI) PARA EL TRATAMIENTO DE PACIENTES CON CÁNCER DE PRÓSTATA RESISTENTE A LA CASTRACIÓN METASTÁSICO (CPRCM) ANTES DEL USO DE DOCETAXEL EN EL INSTITUTO ME ...

    Oct 1, 2019, 00:00

  • PRO13 IMPACT OF CAREGIVER EXPERIENCE AND HRQOL IN LATER-ONSET SPINAL MUSCULAR ATROPHY (SMA): RESULTS FROM THE PHASE 3 CHERISH TRIAL

    Oct 1, 2019, 00:00

  • PNS11 FUNDING OF MANAGEMENT AND INCORPORATION OF TECHNOLOGIES IN BRAZILIAN HEALTH SYSTEM

    Oct 1, 2019, 00:00

  • PMS1 SUSTAINED REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS: EVIDENCE FROM A COHORT FOLLOWED-UP AT A CENTER OF EXCELLENCE IN COLOMBIA

    Oct 1, 2019, 00:00

  • PRS6 LA EVOLUCIÓN DE LA CARGA DE ENFERMEDAD DE LA FIBROSIS PULMONAR IDIOPÁTICA EN LA POBLACIÓN ECUATORIANA DE 2011 A 2017

    Oct 1, 2019, 00:00

  • PCN6 COSTO-EFECTIVIDAD DEL ESQUEMA DABRAFENIB EN COMBINACIÓN CON TRAMETINIB EN COMPARACIÓN CON OTRAS TERAPIAS DIRIGIDAS, INMUNOTERAPIA Y DACARBAZINA PARA EL TRATAMIENTO DE MELANOMA IRRESECABLE O METASTÁSICO CON MUTACIÓN BRAFV600 EN COLOMBIA ...

    Oct 1, 2019, 00:00

  • PAM5 AVALIAÇÃO DO USO DA OZONIOTERAPIA EM PACIENTES COM DOR LOMBAR: UM ESTUDO DE METANALISE

    Oct 1, 2019, 00:00

  • PDG6 EVALUACION ECONOMICA DE DEXAMETASONA IMPLANTE PARA EL TRATAMIENTO DE PACIENTES CON EDEMA MACULAR DIABETICO

    Oct 1, 2019, 00:00

  • PND13 SYSTEMATIC REVIEW OF THE COST OF ILLNESS OF MULTIPLE SCLEROSIS

    Oct 1, 2019, 00:00

  • PNS42 A SURVEY OF PRACTICING PHYSICIANS ON VALUE-BASED HEALTH CARE IN A PRIVATE HEALTH SYSTEM IN BRAZIL

    Oct 1, 2019, 00:00

  • PRS8 HEALTH RESOURCE USE OF COPD PATIENTS IN THE BRAZILIAN PRIVATE HEALTHCARE SETTING

    Oct 1, 2019, 00:00

  • PCN36 EXPERIENCIAS EN LA IMPLEMENTACIÓN DE METODOLOGÍAS O CRITERIOS PARA DETERMINAR EL VALOR TERAPÉUTICO DE MEDICAMENTOS ONCOLÓGICOS: UNA REVISIÓN RÁPIDA DE LA LITERATURA

    Oct 1, 2019, 00:00

  • PMS7 A STANDARD COSTING FOR MODERATE-SEVERE RHEUMATOID ARTHRITIS FROM THE COLOMBIAN HEALTH SYSTEM PERSPECTIVE

    Oct 1, 2019, 00:00

  • PGI1 EFFECTS OF FECAL MICROBIOTA TRANSPLANTATION IN INFLAMMATORY BOWEL DISEASE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2019, 00:00

  • PRO4 COST-EFFECTIVENESS ANALYSIS OF AN INTEGRATED EXTRACORPOREAL PHOTOPHERESIS SYSTEM VERSUS SELECTED TREATMENTS FOR REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE

    Oct 1, 2019, 00:00

  • PCV15 GOOD PRACTICES ASSESSMENT FOR CARDIAC SURGERIES: A REAL WORLD ANALYSIS

    Oct 1, 2019, 00:00

  • PMU7 POPULATION HEALTH IMPACT MODEL

    Oct 1, 2019, 00:00

  • PIN8 ANALISE ECONOMICA DE CUSTOS DE TRATAMENTO DE INFECCOES POR MICROORGANISMOS GRAM-POSITIVOS RESISTENTES: STAPHYLOCOCCUS AUREUS RESISTENTE A METICILINA (MRSA) E ENTEROCOCCUS SPP RESISTENTES A VANCOMICINA (VRE)

    Oct 1, 2019, 00:00

  • PMU14 USO DEL EQ-5D EN MEXICO

    Oct 1, 2019, 00:00

  • PIT6 SELF-INFLICTED LESIONS IN BRAZIL: A DESCRIPTIVE ANALYSIS BETWEEN 2009 AND 2016

    Oct 1, 2019, 00:00

  • PDB11 BUDGET IMPACT ANALYSIS OF SWITCHING FROM ALOGLIPTIN TO VILDAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES

    Oct 1, 2019, 00:00

  • PCN37 FDA NEW DRUGS APPROVAL FOR BREAST, COLORECTAL, PROSTATE AND LUNG CANCER AND HORIZON SCANNING OPPORTUNITY

    Oct 1, 2019, 00:00

  • PMS5 USE OF AN ALGORITHM WITHIN A MULTIDISCIPLINARY CONSULTATION FOR THE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS CANDIDATES FOR BIOLOGICAL THERAPY - A STRATEGY FOR OPTIMIZING COSTS

    Oct 1, 2019, 00:00

  • PDB6 COSTO DE OBESIDAD Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PCN28 OVARIAN CANCER MORTALITY TREND IN BRAZIL: A LINEAR REGRESSION ANALYSIS BETWEEN 1981 AND 2016

    Oct 1, 2019, 00:00

  • PBI10 REAL WORLD SWITCHING PATTERNS OF ETANERCEPT ORIGINAL AND BIOSIMILAR IN GERMANY

    Oct 1, 2019, 00:00

  • PBI4 COMPORTAMIENTO DE USO DE TERAPIA BIOLÓGICA Y COSTOS ASOCIADOS DE UN PROGRAMA DE ATENCIÓN EN PACIENTES CON DIAGNASTICO DE ARTRITIS REUMATOIDE EN COLOMBIA

    Oct 1, 2019, 00:00

  • CL2 EFFECTIVENESS OF TREATMENT WITH DIRECT-ACTING ANTIVIRALS IN THE COLOMBIAN POPULATION WITH CHRONIC HEPATITIS C

    Oct 1, 2019, 00:00

  • PIN6 O IMPACTO ECONOMICO NA AVALIACAO DO INFECTOLOGISTA NO PROGRAMA DE GESTAO CLINICA DO USO DE ANTIMICROBIANOS EM HOSPITAL PRIVADO DE FORTALEZA- CE, BRASIL

    Oct 1, 2019, 00:00

  • PDB14 LOVASTATIN, ATORVASTATIN AND ROSUVASTATIN CONSUMPTION IN COLOMBIA FROM 2010 TO 2017

    Oct 1, 2019, 00:00

  • PMH7 COST-EFFECTIVENESS AND INCORPORATION PRICE OF ARIPIPRAZOLE FOR SCHIZOPHRENIA IN BRAZIL: A SUBSTITUTE TECHNOLOGY APPROACH

    Oct 1, 2019, 00:00

  • TP1 TRATAMIENTO DEL CANCER DE MAMA ESTADIO IV, ANÃLISIS DE LOS DATOS REPORTADOS A LA CUENTA DE ALTO COSTO. COLOMBIA 2017

    Oct 1, 2019, 00:00

  • PSY5 QUALITY OF LIFE OF INDIVIDUALS WITH PSORIASIS IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • PIN9 PUBLIC HEALTH AND ECONOMIC IMPACT OF A GENDER-NEUTRAL QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN COLOMBIA

    Oct 1, 2019, 00:00

  • PMS18 COST-ANALYSIS OF TREATMENT FOR MODERATE AND SEVERE RHEUMATOID ARTHRITIS IN A SPECIALIZED RHEUMATOLOGY CENTER

    Oct 1, 2019, 00:00

  • CM4 TIME TO TREATMENT EFFECT, EVENT-FREE SURVIVAL, AND MOTOR MILESTONE ACHIEVEMENT IN TYPE I SPINAL MUSCULAR ATROPHY PATIENTS TREATED WITH ONASEMNOGENE ABEPARVOVEC (AVXS-101) OR NUSINERSEN CONTRASTED TO NATURAL HISTORY

    Oct 1, 2019, 00:00

  • PNS52 EQ-5D-5L SOCIAL VALUES IN PERU: A NOVEL "LITE” APPROACH

    Oct 1, 2019, 00:00

  • PDB9 ESTUDIO DE COSTOS DE LA HIPOGLICEMIA EN PACIENTES CON DIABETES MELLITUS TIPO 2 DESDE LA PERSPECTIVA DE SALUD PUBLICA DE CHILE

    Oct 1, 2019, 00:00

  • PDB13 ESTIMATION OF PATIENTS WITH INDICATION OF METABOLIC SURGERY IN THE PUBLIC AND PRIVATE SECTORS IN BRAZIL.

    Oct 1, 2019, 00:00

  • PMU6 ANALISIS DE COSTOS EN CUIDADO INTENSIVO Y CUIDADOS INTERMEDIOS DE UNA ASEGURADORA EN SALUD EN COLOMBIA

    Oct 1, 2019, 00:00

  • PMS20 DADOS DE MUNDO REAL DO USO DE IMUNOBIOLOGICOS DE PACIENTES COM ARTRITE REUMATOIDE

    Oct 1, 2019, 00:00

  • PNS36 TRENDS IN UNITED STATES EMERGENCY DEAPARTMENT VISITS AND CHARGES, 2010-2016

    Oct 1, 2019, 00:00

  • PND1 COST-EFFECTIVENESS ANALYSIS OF CLADRIBINE IN HIGH DISEASE ACTIVITY RELAPSE REMITTING MULTIPLE SCLEROSIS IN ARGENTINA

    Oct 1, 2019, 00:00

  • PRS3 IDIOPATHIC PULMONARY FIBROSIS EXACERBATIONS : DIRECT COSTS OF MEDICAL RESOURCES

    Oct 1, 2019, 00:00

  • PIH13 CLINICAL BURDEN AND COSTS ASSOCIATED WITH PNEUMOCOCCAL DISEASE HOSPITALIZATIONS IN OLDER ADULTS IN CURITIBA, BRAZIL

    Oct 1, 2019, 00:00

  • PCN64 ANALISIS COMPARATIVO DE LOS COSTOS DEL PACIENTE CON CARCINOMA HEPATOCELULAR ENTRE REGIMENES CONTRIBUTIVO Y SUBSIDIADO

    Oct 1, 2019, 00:00

  • PNS47 ANÁLISIS PARA LA IMPLEMENTACIÓN DE NUEVOS MODELOS DE ACCESO PARA EL SISTEMA NACIONAL DE SALUD DEL ECUADOR

    Oct 1, 2019, 00:00

  • PNS18 HOW IS SELF-PERCEIVED HEALTH STATUS (EQ-5D) ASSOCIATED WITH PSYCHOSOCIAL FACTORS IN 22 LATIN AMERICAN COUNTRIES?

    Oct 1, 2019, 00:00

  • PNS48 USE OF REAL WORLD DATA FOR DEVELOPMENT OF AN ALGORITHM TO EVALUATE THE COMPLEXITY OF PEOPLE WITH CHRONIC DISEASES CONTROLLING FOR SOCIOECONOMIC AND ENVIRONMENTAL INEQUALITIES

    Oct 1, 2019, 00:00

  • PNS53 DESCRIPTION OF CLINICAL CHARACTERISTICS AND SELF REPORTED WILLINGNESS TO PAY FOR NEW TREATMENTS IN COLOMBIAN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS

    Oct 1, 2019, 00:00

  • PGI6 CARGA DE ENFERMEDAD DIARREICA AGUDA ASOCIADA A MALA CALIDAD DEL AGUA, FALTA DE SANEAMIENTO E HIGIENE DE MANOS EN COLOMBIA, 2016

    Oct 1, 2019, 00:00

  • PIH24 NUEVAMENTE: CALIDAD DE VIDA EN PERSONAS MAYORES DE UN SEGURO PRIVADO DE SALUD EN COLOMBIA

    Oct 1, 2019, 00:00

  • PRO2 IMPACTO ORÇAMENTÁRIO DA IDURSULFASE NO TRATAMENTO DA MUCOPOLISSACARIDOSE TIPO 2

    Oct 1, 2019, 00:00

  • PMD11 REMOTE MONITORING COMPARED TO CONVENTIONAL FOLLOW-UP FOR PATIENTS WITH HEART FAILURE USING IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR: A COST-EFFECTIVENESS ANALYSIS

    Oct 1, 2019, 00:00

  • PCN61 ANALISIS DE CORRELACION DE EQ5D 3L Y EORTC QLQ C30 EN POBLACION COLOMBIANA CON CANCER

    Oct 1, 2019, 00:00

  • PSY2 SECUKINUMAB VS ADALIMUMAB E INFLIXIMAB PARA EL TRATAMIENTO DE ESPONDILITIS ANQUILOSANTE: UN ANÁLISIS DE COSTO POR RESPONDEDOR A LA SEMANA 24 DESDE UNA PERSPECTIVA PERUANA

    Oct 1, 2019, 00:00

  • PCV8 COST-EFFECTIVENESS ANALYSIS OF A RHEOLYTIC THROMBECTOMY SYSTEM FOR THE TREATMENT OF DEEP VEIN THROMBOSIS IN MEXICO

    Oct 1, 2019, 00:00

  • CE4 TRATAMIENTOS PARA LOS PACIENTES CON ESCLEROSIS MULTIPLE REMITENTE RECURRENTE CON ALTA ACTIVIDAD DE LA ENFERMEDAD: ANALISIS COSTO EFECTIVIDAD EN MEXICO

    Oct 1, 2019, 00:00

  • PCN48 HEALTH TECHNOLOGY ASSESSMENT DECISIONS IN ONCOLOGY-RELATED TECHNOLOGIES IN BRAZIL: AN ASSESSMENT CONITEC'S RECOMMENDATIONS FROM 2012-2018

    Oct 1, 2019, 00:00

  • PDG12 EXPERIENCIA INTERNACIONAL EN VALOR TERAPÉUTICO Y PRECIO BASADO EN VALOR. REVISIÓN RÁPIDA DE LA LITERATURA

    Oct 1, 2019, 00:00

  • PCN59 SUBJECT TRAINING IS NEEDED FOR KEY TERMINOLOGY IN ONCOLOGY CLINICAL TRIALS

    Oct 1, 2019, 00:00

  • PMU2 COSTOS DIRECTOS MÉDICOS EN COLOMBIA DESCRITOS EN EL ESTUDIO COMPASS: EVENTOS CARDIACOS AGUDOS MAYORES (MACE) Y EVENTOS ISQUEMICOS SEVEROS EN EXTREMIDADES (MALE)

    Oct 1, 2019, 00:00

  • PRO10 EXPERIENCIA INTERNACIONAL EN EL USO DE ANÁLISIS DE DECISIÓN MULTICRITERIO (MCDA) PARA EVALUAR MEDICAMENTOS HUÉRFANOS: SCOPING REVIEW

    Oct 1, 2019, 00:00

  • PCN38 SYSTEMATIC REVIEW OF RISK SHARING AGREEMENT IN ONCOLOGY: ADVANCES OR MORE OF THE SAME?

    Oct 1, 2019, 00:00

  • PCN47 PEG-ASPARAGINASE E L-ASPARAGINASE NATIVA DE ESCHERICHIA COLI NO TRATAMENTO FARMACOLOGICO DA LEUCEMIA LINFOBLASTICA AGUDA EM CRIANCAS E ADOLESCENTES: UMA REVISAO SISTEMATICA

    Oct 1, 2019, 00:00

  • PSU3 DETERMINACION DE CAMBIOS QUERATOMETRICOS POST QUIRURGICOS EN PACIENTES SOMETIDOS A PRK O LASIK MEDIANTE LASER EXCIMER VISX STAR S4IR

    Oct 1, 2019, 00:00

  • PUK4 FACTORES ASOCIADOS DE LA PROGRESION DE LA ENFERMEDAD RENAL CRONICA EN UN PROGRAMA DE INTERVENCION DEL RIESGO CARDIOVASCULAR DEL CARIBE COLOMBIANO

    Oct 1, 2019, 00:00

  • PMD10 ESTUDIO MULTICÉNTRICO DE COSTOS DEL RECAMBIO PLASMÁTICO TERAPÉUTICO (RPT) CON LOS SISTEMAS DE FILTRACIÓN TRANSMEMBRANA Y DE CENTRIFUGACIÓN EN COLOMBIA

    Oct 1, 2019, 00:00

  • PIN14 INCREMENTAL PUBLIC HEALTH AND ECONOMIC IMPACT LINKED TO HIGHER VACCINE COVERAGE RATE IN A GENDER-NEUTRAL QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN BRAZIL

    Oct 1, 2019, 00:00

  • CL1 PATIENT ACTIVATION MEASURE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ITS IMPORTANCE REGARDING EMPOWERMENT

    Oct 1, 2019, 00:00

  • PNS33 HEALTH PROTECTION POLICIES FOR INTERNATIONAL MIGRANTS IN AN IRREGULAR SITUATION: THE CASE OF CHILE

    Oct 1, 2019, 00:00

  • PDB2 SELF-MONITORING OF BLOOD GLUCOSE (SMBG) LEVELS IN SELECTED LATIN AMERICAN COUNTRIES — HOW DOES IT MEASURE UP TO MAJOR GLUCOSE MONITORING GUIDELINES?

    Oct 1, 2019, 00:00

  • PCV14 IMPACTO DE LA INTERVENCION FARMACEUTICA (IF) EN LA NO ADHERENCIA A TRATAMIENTOS POR OMISION DE RETIRO DE MEDICAMENTOS FINANCIADOS

    Oct 1, 2019, 00:00

  • PMS4 MEDICATION PATTERNS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS - CHARACTERISTICS AND COSTS OF THERAPY

    Oct 1, 2019, 00:00

  • PIH11 ESTIMACION DE LA VARIACION DE COSTOS PRIVADOS E INSTITUCIONALES DE TRATAMIENTO DE LA DISMENORREA PRIMARIA EN MUJERES MEXICANAS.

    Oct 1, 2019, 00:00

  • PCN51 SYSTEMATIC REVIEW AND META-ANALYSIS OF 18F-FDG PET-CT FOR INITIAL STAGING OF PATIENTS WITH ESOPHAGEAL CANCER

    Oct 1, 2019, 00:00

  • PDB18 LA DIABETES Y SUS COMPLICACIONES EN LA ARGENTINA: EL CASO DEL PROGRAMA DE ATENCION INTEGRAL A LOS PACIENTES CON DIABETES MELLITUS EN LAS OBRAS SOCIALES NACIONALES

    Oct 1, 2019, 00:00

  • PND7 COST-EFFECTIVENESS OF CLADRIBINE COMPARED TO NATALIZUMAB, OCRELIZUMAB AND ALEMTUZUMAB FOR THE TREATMENT OF PATIENTS WITH HIGHLY ACTIVE RELAPSING REMITTING MULTIPLE SCLEROSIS IN CHILE

    Oct 1, 2019, 00:00

  • PCN21 ESTUDIO DE COSTO EFECTIVIDAD DE NIVOLUMAB PARA EL TRATAMIENTO DE SEGUNDA LINEA DEL CARCINOMA DE CELULAS RENALES METASTASICO DESDE LA PERSPECTIVA DEL SISTEMA DE SALUD PUBLICO CHILENO

    Oct 1, 2019, 00:00

  • PIN2 SISTEMA ELETRONICO INTEGRADO NO GERENCIAMENTO DO PROGRAMA STEWARDSHIP NUMA OPERADORA DE PLANOS DE SAUDE

    Oct 1, 2019, 00:00

  • PIH1 COSTOS DIRECTOS FARMACÉUTICOS EN PACIENTES ANCIANOS CON POLIFARMACIA EXTREMA MAYOR DE 20 MEDICAMENTOS EN COLOMBIA

    Oct 1, 2019, 00:00

  • PDB16 AVALIAÇÃO DA EFICÁCIA E SEGURANÇA DO USO DO METIMAZOL EM COMPARAÇÁO A PROPILTIOURACILA PARA HIPERTIREOIDISMO

    Oct 1, 2019, 00:00

  • PNS16 ANALYSIS OF THE DEMAND AND CONCESSIONS OF THE CONTINUED CASH BENEFIT FOR PERSONS WITH DISABILITIES UNDER 16 YEARS

    Oct 1, 2019, 00:00

  • PDB15 SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITOR IN TYPE 2 DIABETES: PRESCRIPTION PATTERNS AND TREATMENT OUTCOMES IN ARGENTINA

    Oct 1, 2019, 00:00

  • CR1 LOS COSTOS INDIRECTOS DE LA MORTALIDAD MATERNA EN BRASIL: UN ESTUDIO DE COSTOS DE ENFERMEDADES

    Oct 1, 2019, 00:00

  • CM1 EFECTIVIDAD Y SEGURIDAD DE LA RESECCIÃN MUCOSA ENDOSCÃPICA FRENTE A LA DISECCIÃN SUBMUCOSA EN PACIENTES CON CÃNCER GÃSTRICO TEMPRANO: REVISIÃN SISTEMÃTICA CON METANÃLISIS

    Oct 1, 2019, 00:00

  • HT2 DISEÑO E IMPLEMENTACIÓN DE UN PROCESO DE INVOLUCRAMIENTO ACTIVO DE ACTORES RELEVANTES EN UNA AGENCIA DE EVALUACIÓN DE TECNOLOGÍAS SANITARIAS DE ARGENTINA

    Oct 1, 2019, 00:00

  • PRO6 BURDEN OF ILLNESS OF SPINAL MUSCULAR ATROPHY TYPE 1

    Oct 1, 2019, 00:00

  • PCN68 ADVANCED NON-SMALL CELL LUNG CANCER IN THE PRIVATE HEALTHCARE SYSTEM IN BRAZIL: RETROSPECTIVE COHORT STUDY

    Oct 1, 2019, 00:00

  • PSY3 SECUKINUMAB VS ADALIMUMAB E INFLIXIMAB PARA EL TRATAMIENTO DE ESPONDILITIS ANQUILOSANTE: UN ANÁLISIS DE COSTO POR RESPONDEDOR A LA SEMANA 24 DESDE UNA PERSPECTIVA COLOMBIANA

    Oct 1, 2019, 00:00

  • PCN32 PROSTATE CANCER MORTALITY TREND IN BRAZIL: A LINEAR REGRESSION ANALYSIS BETWEEN 1981 AND 2016

    Oct 1, 2019, 00:00

  • PIH12 THE ECONOMIC IMPACT OF ENDOMETRIOSIS IN BRAZIL DUE TO PRODUCTIVITY LOSS

    Oct 1, 2019, 00:00

  • RE2 Definiendo “Valor” en Latinoamérica: Lo bueno, lo malo y lo feo

    Oct 1, 2019, 00:00

  • PMD2 ANALISIS DE IMPACTO PRESUPUESTARIO Y SANITARIO POR LA INCORPORACION DE UN DISPOSITIVO PORTATIL PARA EL CONTROL DE LOS PACIENTES ANTICOAGULADOS EN LA POBLACION DEL INSTITUTO NACIONAL DE SERVICIOS SOCIALES PARA JUBILADOS Y PENSIONADOS (P ...

    Oct 1, 2019, 00:00

  • PND3 COST-UTILITY ANALYSIS OF NATALIZUMAB AS FIRST LINE THERAPY FOR HIGHLY ACTIVE RELAPSING-REMITTING MULTIPLE SCLEROSIS FROM A BRAZILIAN PRIVATE PAYER PERSPECTIVE

    Oct 1, 2019, 00:00

  • PNS32 COMPARATIVE ANALYSIS OF TENDER LEGISLATION IN BRAZIL AND MEXICO

    Oct 1, 2019, 00:00

  • PNS40 IMPACTO DE LA IMPLEMENTACIÓN DE UNA RED DE ATENCIÓN INTEGRADA EN SERVICIOS DE SALUD EN LA POBLACIÓN DEL NOROCCIDENTE COLOMBIANO

    Oct 1, 2019, 00:00

  • PND10 COMPARATIVE EFFECTIVENESS OF DELAYED-RELEASE DIMETHYL FURMURATE VERSUS OTHER DISEASE-MODIFYING THERAPIES IN PATIENTS WITH MULTIPLE SCLEROSIS: A DIRECT META-ANALYSIS OF REAL-WORLD EVIDENCE

    Oct 1, 2019, 00:00

  • CE1 COSTO-EFECTIVIDAD DE UNA INTERVENCIÃN ECO-SISTÃMICA PARA EL CONTROL DEL DENGUE EN GIRARDOT-COLOMBIA DESDE LA PERSPECTIVA DE LA SOCIEDAD

    Oct 1, 2019, 00:00

  • PMS12 BENEFICIOS CLINICOS Y ECONOMICOS EN LA IMPLEMENTACION DE UNIDADES DE COORDINACION DE FRACTURAS (FLS) EN MEXICO

    Oct 1, 2019, 00:00

  • PCN40 COSTS OF COMPREHENSIVE CARE OF HEPATOCELLULAR CARCINOMA IN A MODEL PUBLIC PROVIDER IN CHILE: IS IT POSSIBLE TO PROMOTE FINANCIAL COVERAGE?

    Oct 1, 2019, 00:00

  • PIH3 BUDGET IMPACT ANALYSIS OF MEDICINES FOR CONTROLLED OVARIAN STIMULATION IN THE TREATMENT OF INFERTILITY IN PATIENTS WITH AN SUBOPTIMAL OVARIAN RESPONSE IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PDG15 SOLICITAÇÃO DE MEDICAMENTOS DO COMPONENTE ESPECIALIZADO NO ESTADO DE MINAS GERAIS: ESTRATÉGIA PARA REDUÇÃO DO TEMPO DE TRAMITAÇÃO E OTIMIZAÇÃO DESSE PROCESSO

    Oct 1, 2019, 00:00

  • PDG7 EVALUACION ECONOMICA DE DEXAMETASONA IMPLANTE PARA EL TRATAMIENTO DE PACIENTES CON EDEMA MACULAR DIABETICO CON FALLA A LA TERAPIA ANTI-VEGF (RANIBIZUMAB O AFLIBERCEPT)

    Oct 1, 2019, 00:00

  • PMU3 COSTOS DIRECTOS DE LA ATENCIÓN EN PACIENTES SUSCEPTIBLES DE CUIDADOS PALIATIVOS, EL CASO DE UNA ASEGURADORA EN SALUD EN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN27 BUDGET IMPACT ANALYSIS OF MIDOSTAURIN IN PATIENTS WITH NEWLY DIAGNOSED FLT3 MUTATION-POSITIVE ACUTE MYELOID LEUKEMIA

    Oct 1, 2019, 00:00

  • PNS38 INVESTIGATING QUALITY AND PERFORMANCE INDICATORS RELATED TO OUTPATIENT CARE USING THE DELPHI METHOD

    Oct 1, 2019, 00:00

  • PIH16 PATRONES DE USO DE ANTICONCEPTIVOS HORMONALES EN UNA POBLACIÓN DE COLOMBIA.

    Oct 1, 2019, 00:00

  • PMU12 A NON-COMMUNICABLE DISEASES MULTI-CRITERIA ANALYSIS IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • PIH14 BURDEN OF PNEUMOCOCCAL DISEASE HOSPITALIZATIONS IN OLDER ADULTS 60Y+ IN FIVE CAPITALS IN BRAZIL

    Oct 1, 2019, 00:00

  • PNS19 AN ANALYSIS OF CONTINUED CASH BENEFIT: PERSONS WITH DISABILITIES OVER 16 YEARS OLD

    Oct 1, 2019, 00:00

  • PIH23 SISTEMATIZACION DE EXPERIENCIAS EN EL DESARROLLO DE UNA ESTRATEGIA NO CONVENCIONAL PARA EDUCAR EN SALUD A GESTANTES DEL PROGRAMA SER MADRE-HIJO DE MUTUAL SER EPS.

    Oct 1, 2019, 00:00

  • PNS17 SELF-PERCEIVED DISCRIMINATION AMONG INTERNATIONAL MIGRANTS IN CHILE: RESULTS FROM A NATIONAL-BASED SURVEY (CASEN) 2017

    Oct 1, 2019, 00:00

  • PIN25 CALIDAD DE REVISIONES SISTEMATICAS CON EVALUACIONES DE COSTO-EFECTIVIDAD DE LA VACUNA CONTRA ROTAVIRUS DE PAISES LATINOAMERICANOS

    Oct 1, 2019, 00:00

  • CN3 SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS OF COLORECTAL CANCER SCREENING STRATEGIES FOR THE EARLY DETECTION OF COLORECTAL CANCER IN THE GENERAL POPULATION

    Oct 1, 2019, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7 (current)
  • 8
  • 9
  • 10
  • »